Disorders of sex development (DSD), NGS

Metabolic Disorders Panel

21 days

Next Generation Sequencing

Genelist (190): AKR1C2, AKR1C4, AMH, AMHR2, ANOS1, AR, ARL6, ARX, ATF3, ATRX, B3GLCT, B9D1, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, BCOR, BMP15, BMP4, BMP7, BNC2, CBX2, CCNQ, CDK9, CDKN1C, CEP41, CHD4, CHD7, CILK1, CKAP2L, CREBBP, CUL7, CYB5A, CYP11A1, CYP11B1, CYP17A1, CYP19A1, CYP21A2, DHCR24, DHCR7, DHH, DMRT1, DMRT2, DNMT3B, DYNC2H1, DYNC2I1, EFNB1, EMX2, EPG5, ERCC3, ESCO2, ESR2, EVC, EVC2, FAT4, FBXL4, FEZF1, FGF10, FGF17, FGF8, FGFR1, FGFR2, FGFR3, FIG4, FLNA, FOXF2, FOXL2, FRAS1, FREM2, FSHB, FSHR, GATA4, GLI3, GNRH1, GNRHR, GPC3, GRIP1, H6PD, HARS2, HBA1, HCCS, HESX1, HFE, HHAT, HNF1B, HOXA10, HOXA13, HOXA4, HOXB6, HS6ST1, HSD17B3, HSD17B4, HSD3B2, IL17RD, INSL3, IRF6, KAL1, KAT6B, KDM5D, KISS1, KISS1R, LEP, LEPR, LHB, LHCGR, LHX1, LHX3, LHX4, LMNA, MAmLD1, MAP3K1, MCM9, MED12, MID1, MKKS, MKRN3, MKS1, MNX1, NEK1, NR0B1, NR3C1, NR5A1, NSMF, OPHN1, PCNT, PCSK1, PDE4D, PEX1, PITX2, POLR3B, POR, PROK2, PROKR2, PROP1, PSMC3IP, PTDSS1, PTPN11, RBBP8, RIPK4, RNF216, ROR2, RSPO1, RXFP2, SALL1, SAMD9, SEMA3A, SETBP1, SGPL1, SHBG, SOS1, SOX10, SOX2, SOX3, SOX9, SPECC1L, SRD5A2, SRY, STAG3, STAR, TAC3, TACR3, TALDO1, TBX15, TCTN3, TMEM70, TNK2, TOE1, TP63, TRAIP, TRIM32, TSPYL1, TTC8, TWIST2, UBR1, VAMP7, WDR11, WDR35, WFS1, WNT4, WNT5A, WNT7A, WNT9B, WT1, WWOX, ZEB2, ZFPM2

Accredited NRL Laboratory

Once a week

Genetic diagnosis of disorders of sex development; clinical decision-making and counseling.

Peripheral Blood

5-7 mL whole blood OR DNA ≥ 100 µL

Lavender-top (EDTA) tube

No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.

This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.